Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
12/2013
12/17/2013CA2720523C Treatment of bladder dysfunction using liposomal botulinum toxin
12/17/2013CA2652499C Pharmaceutical product for intraoral delivery of nicotine comprising trometamol as buffering agent
12/17/2013CA2617051C Ph-controlled pulsatile delivery system, methods for preparation and use thereof
12/17/2013CA2589218C Stable crystal modifications of dotap chloride
12/17/2013CA2585910C Dosage form time-lagged of drugs for the therapy of insomnia
12/17/2013CA2571107C Oral care film
12/17/2013CA2568993C S-tenatoprazole sodium monohydrate salt and the use thereof in the form of a proton pump inhibitor
12/17/2013CA2553254C Long-term delivery formulations and methods of use thereof
12/17/2013CA2543045C Sustained release pharmaceutical compositions comprising aplindore and derivatives thereof
12/17/2013CA2538064C Antibiotic product, use and formulation thereof
12/17/2013CA2504401C Drug delivery systems for the prevention of neointimal hyperlasia
12/17/2013CA2501978C Pharmaceutical composition comprising octreotide microparticles
12/15/2013CA2820236A1 Non-viral nanoparticle-based delivery system
12/13/2013DE202013010193U1 Zusammensetzung zur Verwendung in einer Inhalationsvorrichtung und hierfür einsetzbare Inhalationsvorrichtung A composition for use in an inhalation device and which can be used for this purpose inhalation device
12/12/2013WO2013185105A1 Methods for treating neutropenia using retinoid agonists
12/12/2013WO2013185097A1 Ultrasound-triggerable agents for tissue engineering
12/12/2013WO2013185069A1 Pulmonary delivery of mrna to non-lung target cells
12/12/2013WO2013185032A1 Nanotherapeutics for drug targeting
12/12/2013WO2013184915A1 Hydrogels for delivery of therapeutic polypeptides
12/12/2013WO2013184708A1 Pharmaceutical composition for treating inflammation and pain
12/12/2013WO2013184650A2 Treatment of ocular inflammatory diseases using laquinimod
12/12/2013WO2013184586A1 Method for treating skin inflammatory diseases
12/12/2013WO2013184572A1 Crystalline forms of a bruton's tyrosine kinase inhibitor
12/12/2013WO2013184060A1 Medical device for treatment of wounds
12/12/2013WO2013184029A1 Solid dosage form having expectorant, local coating, and anti-inflammatory effects (variants)
12/12/2013WO2013184024A1 Preparation for increasing sperm production in stud livestock and roosters and method for the use thereof
12/12/2013WO2013184023A1 Composition for treating multiple sclerosis (variants)
12/12/2013WO2013183784A1 Solid preparation
12/12/2013WO2013183778A1 Composition for mucous membranes
12/12/2013WO2013183678A1 Hair growth composition
12/12/2013WO2013183497A1 Dry-coated tablet
12/12/2013WO2013183407A1 Mirtazapine-containing transdermally-absorbable skin-adhesive preparation
12/12/2013WO2013183068A1 Surfactant-copolymer complexes useful for sustained drug release
12/12/2013WO2013183055A1 Compositions comprising apomorphine and organic acids and uses thereof
12/12/2013WO2013182996A1 Mixture for the inhibition of melanin biosynthesis
12/12/2013WO2013182990A1 Oxyclozanide-based veterinary composition for administration to the skin
12/12/2013WO2013182828A1 Aqueous dispersion of polymer particles, film-forming composition containing same and uses thereof
12/12/2013WO2013182806A1 Annelid haemoglobin lyophilisation process
12/12/2013WO2013182688A1 A topical gel composition comprising an ingenol derivative and a solvent mixture
12/12/2013WO2013182653A1 Aqueous gelling compositions of soluble active pharmaceutical peptides providing modified release
12/12/2013WO2013182625A1 Pharmaceutical formulation with propargylamine compound
12/12/2013WO2013182609A1 Stable pharmaceutical compositions with a fast onset
12/12/2013WO2013182170A1 Enhancement of dissolution rate from pharmaceutical composition comprising bazedoxifene acetate
12/12/2013WO2013182169A1 Process of preparation of an antioxidant-free polymorphically and chemically stable formulation of bazedoxifene acetate
12/12/2013WO2013181934A1 Polypeptide with function of synergistic targeted diagnosis and therapy of nasopharyngeal carcinoma, nanoparticles carrying same and use thereof
12/12/2013WO2013158744A3 Nanoparticles of cerium and amino acids
12/12/2013WO2013158680A3 Compositions and methods comprising celecoxib or related compounds and dextromethorphan
12/12/2013WO2013158643A3 Remelted ingestible products
12/12/2013WO2013143683A8 Rna formulation for immunotherapy
12/12/2013WO2012170889A9 Cleavable lipids
12/12/2013US20130331803 Transdermal therapeutic system comprising buprenorphine
12/12/2013US20130331769 Methods for treating headaches
12/12/2013US20130331451 High Concentration Baclofen Preparations
12/12/2013US20130331428 Topical compositions containing a retinoid of the oil-in-water emulsion type
12/12/2013US20130331423 Form of Administration of Enkephalinase Inhibitor
12/12/2013US20130331402 Dosing regimen associated with long-acting injectable paliperidone esters
12/12/2013US20130331393 Therapeutic formulation and methods of treatment
12/12/2013US20130331361 Dosage forms of bisphosphonates
12/12/2013US20130331348 Process for Manufacturing Chewable Dosage Forms for Drug Delivery and Products Thereof
12/12/2013US20130331341 Methods of providing therapeutic effects using cyclosporin components
12/12/2013US20130331340 Methods of providing therapeutic effects using cyclosporin components
12/12/2013US20130331339 Methods of providing therapeutic effects using cyclosporin components
12/12/2013US20130331338 Methods of providing therapeutic effects using cyclosporin components
12/12/2013US20130331337 Methods of providing therapeutic effects using cyclosporin components
12/12/2013US20130331336 Methods of providing therapeutic effects using cyclosporin components
12/12/2013US20130331319 Methods of delivering stable topical drug compositions
12/12/2013US20130331318 Methods of delivering stable topical drug compositions
12/12/2013US20130330415 Method of obtaining viable small tissue particles and use for tissue repair
12/12/2013US20130330412 Smart polymeric nanoparticles which overcome multidrug resistance to cancer therapeutics and treatment-related systemic toxicity
12/12/2013US20130330411 Pharmaceutical cyclosporin compositions
12/12/2013US20130330410 Silica-Coated Calcium Salt Compositions
12/12/2013US20130330409 Dosage Form
12/12/2013US20130330408 Solid particulate compositions comprising coenzyme q10
12/12/2013US20130330407 Oral formulations and lipophilic salts of methylnaltrexone
12/12/2013US20130330406 Bilayer Tablet Formulations
12/12/2013US20130330405 Method of Making a Soft Gel Capsule Comprising CoQ-10 Solubilized in a Monoterpene
12/12/2013US20130330404 Extended release composition containing tramadol
12/12/2013US20130330400 Systems for treating pulmonary infections
12/12/2013US20130330399 Nanoparticle-based tumor-targeted drug delivery
12/12/2013US20130330398 Method of Making Small Liposomes
12/12/2013US20130330396 Methods for the treatment of throat discomfort
12/12/2013US20130330395 Tyrosine Kinase Microspheres
12/12/2013US20130330381 Methods of delivering stable topical drug compositions
12/12/2013US20130330380 Topical drug delivery using phosphatidylcholine
12/12/2013US20130330377 C-Met Modulator Pharmaceutical Compositions
12/12/2013US20130330376 Test of insulin as a drug to reduce restenosis of vessels
12/12/2013US20130330373 Cream composition enhancing skin absorption of glucosamine
12/12/2013US20130330298 Zeaxanthin-enriched poultry egg
12/12/2013US20130327668 Propofol Formulations with Non-Reactive Container Closures
12/12/2013US20130326901 Method for Neutralizing or Recycling Carrier Materials for Film-like Coatings
12/12/2013DE202013000377U1 Zusammensetzung für die topische Anwendung A composition for topical application
12/12/2013DE112012001046T5 Stabile kolloidale Goldnanopartikel mit kontrollierbarer Oberflächenmodifizierung und Funktionalisierung Stable colloidal gold nanoparticles with controllable surface modification and functionalization
12/12/2013DE112010006063T5 Erzeugung von Antigenen, virusartigen Partikeln über Protein-Protein-Bindungen Generation of antigens, virus like particles via protein-protein bonds
12/12/2013CA2876155A1 Pulmonary delivery of mrna to non-lung target cells
12/12/2013CA2876139A1 Nanotherapeutics for drug targeting
12/12/2013CA2875986A1 Crystalline forms of a bruton's tyrosine kinase inhibitor
12/12/2013CA2875604A1 Aqueous dispersion of polymer particles, film-forming composition containing same and uses thereof
12/12/2013CA2875446A1 Compositions comprising apomorphine and organic acids and uses thereof
12/12/2013CA2875054A1 Pharmaceutical composition for treating inflammation and pain
12/12/2013CA2875052A1 Method for treating skin inflammatory diseases
1 ... 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 ... 2991